Evaluation of Bleeding Rates With Sodium Bicarbonate Versus Heparin‐Based Purge Solutions for Impella CP and 5.5 Ventricular Assist Devices

Documenti analoghi

• Trajectories following Impella 5.5 support are associated with initial presentation acuity
  di: Jean‐Luc A. Maigrot, et al.
  Pubblicazione: (2024)
• Outcomes of Impella 5.0 and 5.5 for cardiogenic shock: A single‐center 137 patient experience
  di: Yeahwa Hong, et al.
  Pubblicazione: (2024)
• Axillary artery access considerations in Impella 5.5 insertion: Insights from exclusive axillary approach for successful support
  di: Shazli Khan, et al.
  Pubblicazione: (2024)
• Hemocompatibility‐Related Adverse Events Associated With or Without Low Molecular Weight Heparin Bridging in Outpatients With a HeartMate 3 Left Ventricular Assist Device
  di: Julia R. James, et al.
  Pubblicazione: (2025)
• Vericiguat Experience in Durable Left Ventricular Assist Device Patients
  di: Boaz Elad, et al.
  Pubblicazione: (2025)